Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy

Acta Neurologica Scandinavica

Volumn 107, Issue 4, 2003, Pages 299-301

  Zochodne, D W ^a   Isaac, D ^a   Jones, C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetes mellitus; Diabetic neuropathy; Intravenous gamma grobulin

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; LUMBOSACRAL PLEXUS; MALE; PROPHYLAXIS; TREATMENT FAILURE;

ADULT; AGED; DIABETIC NEUROPATHIES; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; LUMBOSACRAL PLEXUS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 0038364013     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.02107.x     Document Type: Article

References (7)

1. SAID G, ELGRABLY F, LACROIX C et al. Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol 1997;41:762-70.
2. SAID G, GOULON-GOEAU C, LACROIX C, MOULONGUET A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;35:559-69.
3. DYCK PJ, NORELL JEI. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53:2113-21.
4. KRENDEL DA, COSTIGAN DA, HOPKINS LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995;52:1053-61.
5. BAROHN RJ, SAHENK Z, WARMOLTS JR, MENDELL JR, The Bruns-Garland Syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol 1991;48:1130-5.
6. RAFF MC, SANGALANG V, ASBURY AK. Ischemic mononeuropathy multiplex in association with diabetes mellitus. Neurology 1968;18:284.
7. VLASSARA H, BUCALA R, STRIKER L. Biology of disease pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Laboratory Invest 1994;70:138-51.